Literature DB >> 25126662

Profiling the repertoire of T-cell receptor beta-chain variable genes in peripheral blood lymphocytes from subjects who have recovered from acute hepatitis B virus infection.

Jiezuan Yang, Jiajia Chen, Jianqin He, Yirui Xie, Yixing Zhu, Hongcui Cao, Lanjuan Li.   

Abstract

The profile of T-cell receptor beta-chain variable (TRBV) genes usually skews in subjects with virus infection or cancer. The gene melting spectral pattern (GMSP) can be used to determine the profile of the TRBV gene family. To explore the portrait of the TRBV family in peripheral blood lymphocytes from subjects who have recovered from acute hepatitis B virus infection (AHI), peripheral blood mononuclear cells (PBMCs) were separated and further sorted into CD4+ and CD8+ T-cell subsets. The molecular features of the TRBV complementary determining region 3 (CDR3) motifs were determined using GMSP analysis. When aGMSP profile showed a single peak, the monoclonally expanded TRBV gene was cloned and sequenced. Skewed expansions of multiple TRBV genes were observed among the CD4+ and CD8+ T-cell subsets and the PBMCs. The frequency of monoclonally expanded TRBV genes in the CD8+ T-cell subset was significantly higher than that of the CD4+ T-cell subset and the PBMCs. Compared to other members of the TRBV gene family, TRBV11, BV15 and BV20 were predominantly expressed in the repertoire of peripheral blood lymphocytes in recovered AHI subjects. The relatively conserved amino acid motifs of TRBV5.1 and BV20 CDR3 were also detected in the CD4+ and CD8+ T-cell subsets. These results demonstrate the presence of multiple biased TRBV families in recovered AHI subjects. TRBV11, BV15 and BV20, especially from the CD8+ T-cell subset, may be relevant to the pathogenesis of subjects with AHI. The preferentially selected TRBV5.1 and BV20 with the relatively conserved CDR3 motif may be potential targets for personalized treatments of chronic HBV infection.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25126662      PMCID: PMC4085520          DOI: 10.1038/cmi.2014.22

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  49 in total

1.  Cancer regression in patients after transfer of genetically engineered lymphocytes.

Authors:  Richard A Morgan; Mark E Dudley; John R Wunderlich; Marybeth S Hughes; James C Yang; Richard M Sherry; Richard E Royal; Suzanne L Topalian; Udai S Kammula; Nicholas P Restifo; Zhili Zheng; Azam Nahvi; Christiaan R de Vries; Linda J Rogers-Freezer; Sharon A Mavroukakis; Steven A Rosenberg
Journal:  Science       Date:  2006-08-31       Impact factor: 47.728

2.  Chronic hepatitis B.

Authors:  Anna S F Lok; Brian J McMahon
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

3.  Increased levels of arginase in patients with acute hepatitis B suppress antiviral T cells.

Authors:  Elena Sandalova; Diletta Laccabue; Carolina Boni; Tsunamasa Watanabe; Anthony Tan; Ho Zi Zong; Carlo Ferrari; Antonio Bertoletti
Journal:  Gastroenterology       Date:  2012-04-01       Impact factor: 22.682

4.  Mobilizing monocytes to cross-present circulating viral antigen in chronic infection.

Authors:  Adam J Gehring; Muzlifah Haniffa; Patrick T Kennedy; Zi Zong Ho; Carolina Boni; Amanda Shin; Nasirah Banu; Adeline Chia; Seng Gee Lim; Carlo Ferrari; Florent Ginhoux; Antonio Bertoletti
Journal:  J Clin Invest       Date:  2013-08-01       Impact factor: 14.808

5.  Skewed T-cell receptor BV14 and BV16 expression and shared CDR3 sequence and common sequence motifs in synovial T cells of rheumatoid arthritis.

Authors:  W Sun; H Nie; N Li; Y C Q Zang; D Zhang; G Feng; L Ni; R Xu; S Prasad; R R Robinson; W Ho; E Sercarz; J Z Zhang
Journal:  Genes Immun       Date:  2005-05       Impact factor: 2.676

6.  Longitudinal analysis of the T-cell receptor (TCR)-VA and -VB repertoire in CD8+ T cells from individuals immunized with recombinant hepatitis B surface antigen.

Authors:  H Höhn; C Neukirch; K Freitag; A Necker; W Hitzler; B Seliger; M J Maeurer
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

7.  Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection.

Authors:  Michael A Paley; Daniela C Kroy; Pamela M Odorizzi; Jonathan B Johnnidis; Douglas V Dolfi; Burton E Barnett; Elizabeth K Bikoff; Elizabeth J Robertson; Georg M Lauer; Steven L Reiner; E John Wherry
Journal:  Science       Date:  2012-11-30       Impact factor: 47.728

8.  A highly tilted binding mode by a self-reactive T cell receptor results in altered engagement of peptide and MHC.

Authors:  Dhruv K Sethi; David A Schubert; Anne-Kathrin Anders; Annie Heroux; Daniel A Bonsor; Chantz P Thomas; Eric J Sundberg; Jason Pyrdol; Kai W Wucherpfennig
Journal:  J Exp Med       Date:  2011-01-03       Impact factor: 14.307

9.  Relative quantification of TCR Vbeta-chain families by real time PCR for identification of clonal T-cell populations.

Authors:  Sebastian Ochsenreither; Alberto Fusi; Antonia Busse; Dirk Nagorsen; David Schrama; Jürgen Becker; Eckhard Thiel; Ulrich Keilholz
Journal:  J Transl Med       Date:  2008-07-01       Impact factor: 5.531

10.  Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection.

Authors:  Abhishek Das; Matthew Hoare; Nathan Davies; A Ross Lopes; Claire Dunn; Patrick T F Kennedy; Graeme Alexander; Helene Finney; Alistair Lawson; Fiona J Plunkett; Antonio Bertoletti; Arne N Akbar; Mala K Maini
Journal:  J Exp Med       Date:  2008-08-11       Impact factor: 14.307

View more
  10 in total

1.  HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children.

Authors:  Rebecca A Porritt; Lisa Paschold; Magali Noval Rivas; Mary Hongying Cheng; Lael M Yonker; Harsha Chandnani; Merrick Lopez; Donjete Simnica; Christoph Schultheiß; Chintda Santiskulvong; Jennifer Van Eyk; John K McCormick; Alessio Fasano; Ivet Bahar; Mascha Binder; Moshe Arditi
Journal:  J Clin Invest       Date:  2021-05-17       Impact factor: 14.808

2.  The frequency and skewed T-cell receptor beta-chain variable patterns of peripheral CD4(+)CD25(+) regulatory T-cells are associated with hepatitis B e antigen seroconversion of chronic hepatitis B patients during antiviral treatment.

Authors:  Jiezuan Yang; Guoping Sheng; Dangsheng Xiao; Haiyan Shi; Wei Wu; Haifeng Lu; Hongcui Cao; Lanjuan Li
Journal:  Cell Mol Immunol       Date:  2016-02-22       Impact factor: 11.530

3.  High-Throughput Analysis of the T Cell Receptor Beta Chain Repertoire in PBMCs from Chronic Hepatitis B Patients with HBeAg Seroconversion.

Authors:  Yachao Qu; Yong Huang; Di Liu; Yinuo Huang; Zhiyi Zhang; Zhiqiang Mi; Xiaoping An; Yigang Tong; Jun Lu
Journal:  Can J Infect Dis Med Microbiol       Date:  2016-10-13       Impact factor: 2.471

4.  Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical use.

Authors:  Karin Wisskirchen; Kai Metzger; Sophia Schreiber; Theresa Asen; Luise Weigand; Christina Dargel; Klaus Witter; Elisa Kieback; Martin F Sprinzl; Wolfgang Uckert; Matthias Schiemann; Dirk H Busch; Angela M Krackhardt; Ulrike Protzer
Journal:  PLoS One       Date:  2017-08-08       Impact factor: 3.240

5.  Peripheral blood lymphocyte subset levels differ in patients with hepatocellular carcinoma.

Authors:  Hai-Zhou Liu; Wei Deng; Ji-Lin Li; Ya-Mei Tang; Li-Tu Zhang; Ying Cui; Xin-Qiang Liang
Journal:  Oncotarget       Date:  2016-11-22

6.  Predictive value of serum ALT and T-cell receptor beta variable chain for HBeAg seroconversion in chronic hepatitis B patients during tenofovir treatment.

Authors:  Jiezuan Yang; Dong Yan; Renyong Guo; Jiajia Chen; Yongtao Li; Jun Fan; Xuyan Fu; Xinsheng Yao; Hongyan Diao; Lanjuan Li
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

7.  Characteristics Peripheral Blood IgG and IgM Heavy Chain Complementarity Determining Region 3 Repertoire before and after Immunization with Recombinant HBV Vaccine.

Authors:  Long Ma; Xiaomei Wang; Xiaoying Bi; Jiezuan Yang; Bin Shi; Xiaoyan He; Rui Ma; Qingqing Ma; Xinsheng Yao
Journal:  PLoS One       Date:  2017-01-23       Impact factor: 3.240

8.  Dynamic Perturbations of CD4 and CD8 T Cell Receptor Repertoires in Chronic Hepatitis B Patients upon Oral Antiviral Therapy.

Authors:  Ying Xu; Yu Liu; Miaoxian Zhao; Yunqing Chen; Cantao Xie; Mingxing Gong; Haohui Deng; Xueying Li; Jian Sun; Jinlin Hou; Hongkai Wu; Zhanhui Wang
Journal:  Front Immunol       Date:  2017-09-14       Impact factor: 7.561

9.  Restricted TcR β chain CDR3 clonotype is associated with resolved acute hepatitis B subjects.

Authors:  Dangsheng Xiao; Ju Wang; Zhitao Chen; Xiuyuan Jin; Yirui Xie; Dong Yan; Jiezuan Yang
Journal:  BMC Infect Dis       Date:  2021-01-23       Impact factor: 3.090

10.  Analysis of the complementarity determining regions β-chain genomic rearrangement using high-throughput sequencing in periphery cytotoxic T lymphocytes of patients with chronic hepatitis B.

Authors:  Yinuo Huang; Hong Ma; Shutang Wei; Gang Luo; Ruimin Sun; Zhibo Fan; Liping Wu; Wenyi Yang; Lin Fu; Junhui Wang; Dazheng Han; Jun Lu
Journal:  Mol Med Rep       Date:  2016-05-23       Impact factor: 2.952

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.